🇺🇸 FDA
Patent

US 6100252

Heterocyclic compounds and their use as angiotensin antagonists

expired A61KA61K31/42A61K31/435

Quick answer

US patent 6100252 (Heterocyclic compounds and their use as angiotensin antagonists) held by Takeda Chemical Industries Ltd. expires Mon Aug 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Takeda Chemical Industries Ltd.
Grant date
Tue Aug 08 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/42, A61K31/435, A61P, A61P25/28